STOCK TITAN

Pyxus Intl New (PYYX) 10-K Filings

PYYX OTC

Here are the 10-K annual reports from Pyxus Intl Inc New (PYYX) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow PYYX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PYYX filings page.

Rhea-AI Summary

Pyxus International files its annual report showing $2,413.0 million in tobacco sales for the year ended March 31, 2026. The global leaf business remains the core, with Africa, Asia, Europe and other regions all contributing meaningfully.

The company carries $932.9 million of indebtedness and relies heavily on short- and long-term credit facilities, with $747.3 million available for borrowing at year-end. Tobacco inventories were $786.7 million, positioning Pyxus for more carry-over sales into fiscal 2027, but also tying up working capital.

Operations are highly concentrated: three multinational tobacco manufacturers each contributed at least 10% of annual revenue, and non-tobacco crops were less than 1% of sales. Pyxus employs about 3,300 people worldwide and faces risks from high leverage, volatile crop conditions, regulation of tobacco and nicotine products, and geopolitical and currency pressures across its many sourcing regions.